Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 10, Issue 2 (2021)

Amelioration of experimental hepatotoxicity and nephrotoxicity due to cisplatin by Terminalia arjuna in comparison to taurine

Author(s):
K Sneha, A Gopala Reddy, M Usha Rani, B Ramya, P Shiva Kumar and B Anil Kumar
Abstract:
The ameliorative potential of aqueous leaf extract of Terminalia arjuna and taurine were studied against Cisplatin induced nephrotoxicity and hepatotoxicity. Total 36 male Wistar rats were separated into six groups (n = 6). Group 1 was maintained as normal control. A single dose of Cisplatin (5 mg/kg i.p) was administered on day 1 to groups 2, 5 and 6. Groups 3 and 5 were administered for 14 days (p/o) with aqueous leaf extract of Terminalia arjuna @ 400 mg/kg bodyweight from day 1. Group 4 and 6 received received taurine @ 1000 mg/kg body weight orally for 14 days. After the experimental procedure, body weight, total protein and prothrombin time were assessed.
In the present study, body weights and total protein showed a significant (P < 0.05) reduction in group 2 when compared with group 1 and there was significant (P < 0.05) improvement in the treatment groups 5 and 6. The results of prothrombin time revealed a significant (P < 0.05) increase in group 2 and significant (P < 0.05) decrease in groups 5 and 6 compared to group 2. In conclusion, aqueous leaf extract of Terminalia arjuna and taurine were found to possess protective action against Cisplatin induced nephrotoxicity and hepatotoxicity.
Pages: 567-571  |  180 Views  45 Downloads


The Pharma Innovation Journal
How to cite this article:
K Sneha, A Gopala Reddy, M Usha Rani, B Ramya, P Shiva Kumar, B Anil Kumar. Amelioration of experimental hepatotoxicity and nephrotoxicity due to cisplatin by Terminalia arjuna in comparison to taurine. Pharma Innovation 2021;10(2):567-571.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter